bioAffinity Technologies (BIAF) EPS (Weighted Average and Diluted) (2022 - 2026)
bioAffinity Technologies (BIAF) reported EPS (Weighted Average and Diluted) of -$0.81 for Q1 2026, up 83.12% year-over-year from -$0.44 in Q1 2025, and up 27.03% quarter-over-quarter from -$1.11 in Q4 2025.
bioAffinity Technologies (BIAF) EPS (Weighted Average and Diluted) (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 5 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.81 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.81, up 83.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.83 (up 57.6% YoY), and the FY2025 annual result was -$8.66, up 61.51% from the prior year.
- EPS (Weighted Average and Diluted) rose to -$0.81 in Q1 2026 per BIAF's latest filing, from -$1.11 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.22 in Q4 2022 and troughed at -$6.28 in Q4 2024.
- A 5-year average of -$1.56 and a median of -$0.26 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2026: EPS (Weighted Average and Diluted) sank 2315.38% in 2024, then jumped 83.12% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.22 in 2022, then slumped by 218.18% to -$0.26 in 2023, then slumped by 2315.38% to -$6.28 in 2024, then soared by 82.32% to -$1.11 in 2025, then climbed by 27.03% to -$0.81 in 2026.
- Business Quant data shows BIAF's EPS (Weighted Average and Diluted) at -$0.81 in Q1 2026, -$1.11 in Q4 2025, and -$4.74 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 4.43 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.47 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.20 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -0.60 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.61 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 0.87 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 8.33 |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | -0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.81 |
| Dec 31, 2025 | -1.11 |
| Sep 30, 2025 | -4.74 |
| Jun 30, 2025 | -0.17 |
| Mar 31, 2025 | -4.80 |
| Dec 31, 2024 | -6.28 |
| Sep 30, 2024 | -4.84 |
| Jun 30, 2024 | -0.19 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | -0.26 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.20 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | 0.22 |
| Sep 30, 2022 | -1.17 |
| Jun 30, 2022 | -0.03 |